Literature DB >> 19073416

Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Tomas Palomo1, Richard M Kostrzewa, Richard J Beninger, Trevor Archer.   

Abstract

Several avenues of investigation through which the 'labyrinths' of schizopsychotic diagnosis may be examined, are offered by the consideration of the 'beacons' of symptom-profiles and biomarkers. Neurodevelopmental issues and risk assessment, neurocognitive factors of predictive necessity, supersensitivity in neurotransmitter systems, the implications of prodromal expressions of the disorder, functional dysconnectivity arising from prefrontal to diverse regional patterns and circuits with a neurodevelopmental origin, and heritable gene characteristics are viewed against the backdrop of the schizophrenia spectrum disorders. The associations between adolescent-adult use of cannabis, on the one hand, and, alternatively, the prevalence of chromosomal abnormalities, e.g., GRIK4 and NPAS3, and mental retardation, on the other hand, with the symptom-profiles of schizopsychosis provide further evidence of emerging biomarkers of biological inheritance factors. The involvement of dopamine D1 and D2 receptors, particularly in prefrontal region, with regard to functional integrity of cognitive systems is reviewed. It would appear that considerations of these disorders imply that one essential hub around which much of the neuropathology revolves may be observed in the various expressions of the cognitive and structural insufficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073416     DOI: 10.1007/BF03033800

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  269 in total

1.  Recognizing a common genetic syndrome: 22q11.2 deletion syndrome.

Authors:  Ronak K Kapadia; Anne S Bassett
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

Review 2.  Stress and the mesocorticolimbic dopamine systems.

Authors:  R H Roth; S Y Tam; Y Ida; J X Yang; A Y Deutch
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 3.  Psychosis treatment prior to psychosis onset: ethical issues.

Authors:  T H McGlashan
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

4.  Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia.

Authors:  L M Talamini; T Koch; G J Ter Horst; J Korf
Journal:  Brain Res       Date:  1998-04-13       Impact factor: 3.252

5.  Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study.

Authors:  Linda E Campbell; Eileen Daly; Fiona Toal; Angela Stevens; Rayna Azuma; Marco Catani; Virginia Ng; Therese van Amelsvoort; Xavier Chitnis; William Cutter; Declan G M Murphy; Kieran C Murphy
Journal:  Brain       Date:  2006-03-28       Impact factor: 13.501

6.  Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability.

Authors:  Ben S Pickard; M P Malloy; D J Porteous; D H R Blackwood; W J Muir
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-07-05       Impact factor: 3.568

7.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 9.  Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

Authors:  S Kristian Hill; Margret S H Harris; Ellen S Herbener; Mani Pavuluri; John A Sweeney
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

10.  Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.

Authors:  G R Breese; A Baumeister; T C Napier; G D Frye; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

View more
  3 in total

Review 1.  Stereotypic progressions in psychotic behavior.

Authors:  Richard M Kostrzewa; John P Kostrzewa; Rose Anna Kostrzewa; Florence P Kostrzewa; Ryszard Brus; Przemyslaw Nowak
Journal:  Neurotox Res       Date:  2010-04-22       Impact factor: 3.911

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.